News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pernix Therapeutics, Inc. (PTX) Reports First Quarter 2013 Financial Results


5/10/2013 7:44:20 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ: PTX), a specialty pharmaceutical company, today announced financial results for the quarter ended March 31, 2013.

Financial Results

For the first quarter of 2013, net revenues increased by approximately 52% to $22.1 million, compared to $14.5 million for the first quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES